Patents by Inventor Maud Brandely

Maud Brandely has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF A POXVIRUS ENCODING HPV POLYPEPTIDES WITH AN ANTI-PD-L1 ANTIBODY
    Publication number: 20230405105
    Abstract: The present invention relates to a combination of a) a poxvirus vector encoding at least human papillomavirus (HPV) E6 and E7 polypeptides and an immunostimulatory cytokine, and b) an anti-PD-L1 antibody or antigen-binding fragment thereof, for use in the treatment of an HPV-positive cancer, wherein a first administration of said poxvirus is performed 5 to 10 days before the first administration of said anti-PD-L1 antibody, and subsequent administrations of said poxvirus and anti-PD-L1 antibody are performed.
    Type: Application
    Filed: September 21, 2020
    Publication date: December 21, 2023
    Inventors: Kaidre BENDJAMA, Maud BRANDELY-TALBOT, Annette TAVERNARO
  • Treatment of leukemia using interleukin 2
    Patent number: 5582822
    Abstract: A method of treating leukemia in warm-blooded animals suffering from leukemia comprising administering to said warm-blooded animals an amount of polypeptide having human interleukin 2 activity sufficient to treat leukemia.
    Type: Grant
    Filed: September 30, 1994
    Date of Patent: December 10, 1996
    Assignee: Roussel Uclaf
    Inventors: Maud Brandely, Dominique Maraninchi
  • Antitumoral composition based on polypeptides having human interleukin 2 activity
    Patent number: 5358709
    Abstract: The use of a polypeptide having human interleukin 2 activity for preparing a pharmaceutical composition for treating malignant epithelial tumours of the upper respiratory/alimentary tract or the thymus, is described.
    Type: Grant
    Filed: July 8, 1992
    Date of Patent: October 25, 1994
    Assignee: Roussel Uclaf
    Inventors: Thomas Tursz, Maud Brandely
  • Treatment method of ovarian cancer using interferon gamma
    Patent number: 5268169
    Abstract: A method of treating ovarian cancer in warm-blooded animals comprising intraperitoneally administering to warm-blooded animals by perfusion a recombinant polypeptide of human gamma interferon type with a specific activity at least equal to 1.times.10.sup.7 U/mg in an anti-cancer effective amount.
    Type: Grant
    Filed: April 13, 1992
    Date of Patent: December 7, 1993
    Assignee: Roussel Uclaf
    Inventors: Maud Brandely, Danielle Lando
  • Treatment of primary cancers of the pleura
    Patent number: 5219565
    Abstract: A method for treating primary cancers of the pleura in humans comprising administering to humans an amount of a polyprotein having human interleukin activity sufficient to treat primary cancers of the pleura.
    Type: Grant
    Filed: June 8, 1990
    Date of Patent: June 15, 1993
    Assignee: Roussel Uclaf
    Inventors: Maud Brandely, Danielle Lando
  • Treatment of pneumothorax
    Patent number: 5204094
    Abstract: A method of treating pneumothoraxes in warm-blooded animals comprising administering to warm-blooded animals an amount of polypeptide having human interleukin 2 activity sufficient to treat pneumothoraxes.
    Type: Grant
    Filed: January 16, 1992
    Date of Patent: April 20, 1993
    Assignee: Roussel Uclaf
    Inventors: Maud Brandely, Christian Boutin
  • Method of treating primary cancers of the pleura
    Patent number: 5108743
    Abstract: A method of treating primary cancers of pleura in warm-blooded animals having said cancers comprising administering to said warm-blooded animals an amount of a polypeptide having human gamma interferon activity sufficient to treat primary cancers of pleura.
    Type: Grant
    Filed: October 30, 1990
    Date of Patent: April 28, 1992
    Assignee: Roussel Uclaf
    Inventors: Maud Brandely, Danielle Lando